Skip to main content
Erschienen in: Quality of Life Research 5/2009

01.06.2009

Are gender-associated differences in quality of life in colorectal cancer patients disease-specific?

verfasst von: Johannes Giesinger, Georg Kemmler, Verena Mueller, August Zabernigg, Beate Mayrbaeurl, Josef Thaler, Dietmar Öfner, Christian Pegger, Gerhard Rumpold, Barbara Weber, Barbara Sperner-Unterweger, Bernhard Holzner

Erschienen in: Quality of Life Research | Ausgabe 5/2009

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of this study was to investigate gender-associated differences in quality of life in colorectal cancer patients and compare such differences to the general population.

Methods

Colorectal cancer patients attending three oncological centres in Austria were consecutively recruited and assessed with the EORTC QLQ-C30. For the purpose of comparison, a gender- and age-matched healthy control group was drawn from a representative sample of the Austrian general population.

Results

About 206 patients (47.1% women; mean age 64.8 years) with colorectal cancer were included and compared with 206 persons from the general population. A two-way analysis of variance showed significant main effects (gender and colorectal cancer vs. healthy) for most EORTC QLQ-C30 scales, but a significant interaction effect was only found for diarrhea. This means that gender-associated differences specific for colorectal cancer patients were only found for diarrhea.

Conclusion

The vast majority of studies on gender-associated differences in quality of life compare male and female oncological patients and neglect the issue of the disease-specificity of such differences. Our study revealed that women and men suffering from colorectal cancer scored differently across many aspects of quality of life, but with the exception of diarrhea, these differences were also found in the general population, i.e. they indicated no gender-specific reaction to disease.
Literatur
2.
Zurück zum Zitat Oberaigner, W., Mühlböck, H., & Harrasser, L. (2004). Kolorektale Karzinome in Tirol. Innsbruck: Institut für Klinische Epidemiologie. Oberaigner, W., Mühlböck, H., & Harrasser, L. (2004). Kolorektale Karzinome in Tirol. Innsbruck: Institut für Klinische Epidemiologie.
4.
Zurück zum Zitat McArdle, C. S., McMillan, D. C., & Hole, D. J. (2003). Male gender adversely affects survival following surgery for colorectal cancer. British Journal of Surgery, 90(6), 711–715. doi:10.1002/bjs.4098.PubMedCrossRef McArdle, C. S., McMillan, D. C., & Hole, D. J. (2003). Male gender adversely affects survival following surgery for colorectal cancer. British Journal of Surgery, 90(6), 711–715. doi:10.​1002/​bjs.​4098.PubMedCrossRef
5.
Zurück zum Zitat Wong, N. D., Pio, J., Valencia, R., & Thakal, G. (2001). Distribution of C-reactive protein and its relation to risk factors and coronary heart disease risk estimation in the National Health and Nutrition Examination Survey (NHANES) III. Preventive Cardiology, 4, 109–114. doi:10.1111/j.1520-037X.2001.00570.x.PubMedCrossRef Wong, N. D., Pio, J., Valencia, R., & Thakal, G. (2001). Distribution of C-reactive protein and its relation to risk factors and coronary heart disease risk estimation in the National Health and Nutrition Examination Survey (NHANES) III. Preventive Cardiology, 4, 109–114. doi:10.​1111/​j.​1520-037X.​2001.​00570.​x.PubMedCrossRef
6.
Zurück zum Zitat Winawer, S. J., Fletcher, R. H., Miller, L., Godlee, F., Stolar, M. H., Mulrow, C. D., et al. (1997). Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology, 112(2), 594–642.PubMedCrossRef Winawer, S. J., Fletcher, R. H., Miller, L., Godlee, F., Stolar, M. H., Mulrow, C. D., et al. (1997). Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology, 112(2), 594–642.PubMedCrossRef
9.
Zurück zum Zitat Blom, J., Yin, L., Liden, A., Dolk, A., Jeppsson, B., Paahlman, L., et al. (2008). Toward understanding nonparticipation in sigmoidoscopy screening for colorectal cancer. International Journal of Cancer, 122(7), 1618–1623. doi:10.1002/ijc.23208.CrossRef Blom, J., Yin, L., Liden, A., Dolk, A., Jeppsson, B., Paahlman, L., et al. (2008). Toward understanding nonparticipation in sigmoidoscopy screening for colorectal cancer. International Journal of Cancer, 122(7), 1618–1623. doi:10.​1002/​ijc.​23208.CrossRef
10.
Zurück zum Zitat Schmidt, C. E., Bestmann, B., Kuchler, T., Longo, W. E., Rohde, V., & Kremer, B. (2005). Gender differences in quality of life of patients with rectal cancer. A five-year prospective study. World Journal of Surgery, 29(12), 1630–1641. doi:10.1007/s00268-005-0067-0.PubMedCrossRef Schmidt, C. E., Bestmann, B., Kuchler, T., Longo, W. E., Rohde, V., & Kremer, B. (2005). Gender differences in quality of life of patients with rectal cancer. A five-year prospective study. World Journal of Surgery, 29(12), 1630–1641. doi:10.​1007/​s00268-005-0067-0.PubMedCrossRef
11.
12.
Zurück zum Zitat Arndt, V., Merx, H., Stegmaier, C., Ziegler, H., & Brenner, H. (2004). Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: A population-based study. Journal of Clinical Oncology, 22(23), 4829–4836. doi:10.1200/JCO.2004.02.018.PubMedCrossRef Arndt, V., Merx, H., Stegmaier, C., Ziegler, H., & Brenner, H. (2004). Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: A population-based study. Journal of Clinical Oncology, 22(23), 4829–4836. doi:10.​1200/​JCO.​2004.​02.​018.PubMedCrossRef
13.
Zurück zum Zitat Heinonen, H., Volin, L., Uutela, A., Zevon, M., Barrick, C., & Ruutu, T. (2001). Gender-associated differences in the quality of life after allogeneic BMT. Bone Marrow Transplantation, 28(5), 503–509. doi:10.1038/sj.bmt.1703158.PubMedCrossRef Heinonen, H., Volin, L., Uutela, A., Zevon, M., Barrick, C., & Ruutu, T. (2001). Gender-associated differences in the quality of life after allogeneic BMT. Bone Marrow Transplantation, 28(5), 503–509. doi:10.​1038/​sj.​bmt.​1703158.PubMedCrossRef
14.
Zurück zum Zitat Mystakidou, K., Tsilika, E., Parpa, E., Katsouda, E., Galanos, A., & Vlahos, L. (2005). Assessment of anxiety and depression in advanced cancer patients and their relationship with quality of life. Quality of Life Research, 14(8), 1825–1833. doi:10.1007/s11136-005-4324-3.PubMedCrossRef Mystakidou, K., Tsilika, E., Parpa, E., Katsouda, E., Galanos, A., & Vlahos, L. (2005). Assessment of anxiety and depression in advanced cancer patients and their relationship with quality of life. Quality of Life Research, 14(8), 1825–1833. doi:10.​1007/​s11136-005-4324-3.PubMedCrossRef
15.
Zurück zum Zitat Jordhoy, M., Fayers, P., Loge, J., Saltnes, T., Ahlner-Elmqvist, M., & Kaasa, S. (2001). Quality of life in advanced cancer patients: The impact of sociodemographic and medical characteristics. British Journal of Cancer, 85(10), 1478–1485. doi:10.1054/bjoc.2001.2116.PubMedCrossRef Jordhoy, M., Fayers, P., Loge, J., Saltnes, T., Ahlner-Elmqvist, M., & Kaasa, S. (2001). Quality of life in advanced cancer patients: The impact of sociodemographic and medical characteristics. British Journal of Cancer, 85(10), 1478–1485. doi:10.​1054/​bjoc.​2001.​2116.PubMedCrossRef
16.
Zurück zum Zitat Holzner, B., Kemmler, G., Kopp, M., Nguyen-Van-Tam, D., Sperner-Unterweger, B., & Greil, R. (2004). Quality of life of patients with chronic lymphocytic leukemia: Results of a longitudinal investigation over 1 yr. European Journal of Haematology, 72(6), 381–389. doi:10.1111/j.1600-0609.2004.00233.x.PubMedCrossRef Holzner, B., Kemmler, G., Kopp, M., Nguyen-Van-Tam, D., Sperner-Unterweger, B., & Greil, R. (2004). Quality of life of patients with chronic lymphocytic leukemia: Results of a longitudinal investigation over 1 yr. European Journal of Haematology, 72(6), 381–389. doi:10.​1111/​j.​1600-0609.​2004.​00233.​x.PubMedCrossRef
17.
Zurück zum Zitat Holzner, B., Kemmler, G., Cella, D., De Paoli, C., Meraner, V., Kopp, M., et al. (2004). Normative data for functional assessment of cancer therapy—general scale and its use for the interpretation of quality of life scores in cancer survivors. Acta Oncologica (Stockholm, Sweden), 43(2), 153–160. doi:10.1080/02841860310023453.CrossRef Holzner, B., Kemmler, G., Cella, D., De Paoli, C., Meraner, V., Kopp, M., et al. (2004). Normative data for functional assessment of cancer therapy—general scale and its use for the interpretation of quality of life scores in cancer survivors. Acta Oncologica (Stockholm, Sweden), 43(2), 153–160. doi:10.​1080/​0284186031002345​3.CrossRef
18.
Zurück zum Zitat Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376. doi:10.1093/jnci/85.5.365.PubMedCrossRef Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376. doi:10.​1093/​jnci/​85.​5.​365.PubMedCrossRef
20.
Zurück zum Zitat Holzner, B., Zabernigg, A., Kemmler, G., Baier, S., Kopp, M., & Sperner Unterweger, B. (2004). Computerized assessment of quality of life in patients undergoing chemotherapy. Quality of Life Research, 13(9), 1523. Holzner, B., Zabernigg, A., Kemmler, G., Baier, S., Kopp, M., & Sperner Unterweger, B. (2004). Computerized assessment of quality of life in patients undergoing chemotherapy. Quality of Life Research, 13(9), 1523.
21.
Zurück zum Zitat Osoba, D., Rodrigues, G., Myles, J., Zee, B., & Pater, J. (1998). Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology, 16(1), 139–144.PubMed Osoba, D., Rodrigues, G., Myles, J., Zee, B., & Pater, J. (1998). Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology, 16(1), 139–144.PubMed
22.
Zurück zum Zitat Fayers, P., & Machin, D. (2000). Quality of life: Assessment, analysis and interpretation. Chichester: Wiley. Fayers, P., & Machin, D. (2000). Quality of life: Assessment, analysis and interpretation. Chichester: Wiley.
24.
Zurück zum Zitat Miaskowski, C. (2004). Gender differences in pain, fatigue, and depression in patients with cancer. Journal of the National Cancer Institute. Monographs, 32, 139–143.PubMedCrossRef Miaskowski, C. (2004). Gender differences in pain, fatigue, and depression in patients with cancer. Journal of the National Cancer Institute. Monographs, 32, 139–143.PubMedCrossRef
25.
Zurück zum Zitat Sloan, J. A., Goldberg, R. M., Sargent, D. J., Vargas-Chanes, D., Nair, S., Cha, S. S., et al. (2002). Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer. Journal of Clinical Oncology, 20(6), 1491–1498. doi:10.1200/JCO.20.6.1491.PubMedCrossRef Sloan, J. A., Goldberg, R. M., Sargent, D. J., Vargas-Chanes, D., Nair, S., Cha, S. S., et al. (2002). Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer. Journal of Clinical Oncology, 20(6), 1491–1498. doi:10.​1200/​JCO.​20.​6.​1491.PubMedCrossRef
26.
Zurück zum Zitat Chansky, K., Benedetti, J., & Macdonald, J. S. (2005). Differences in toxicity between men and women treated with 5-fluorouracil therapy for colorectal carcinoma. Cancer, 103(6), 1165–1171. doi:10.1002/cncr.20878.PubMedCrossRef Chansky, K., Benedetti, J., & Macdonald, J. S. (2005). Differences in toxicity between men and women treated with 5-fluorouracil therapy for colorectal carcinoma. Cancer, 103(6), 1165–1171. doi:10.​1002/​cncr.​20878.PubMedCrossRef
27.
28.
Zurück zum Zitat Wilson, T., & Alexander, D. (2008). Clinical and non-clinical factors influencing postoperative health-related quality of life in patients with colorectal cancer. British Journal of Surgery, 95(11), 1408–1415. doi:10.1002/bjs.6376.PubMedCrossRef Wilson, T., & Alexander, D. (2008). Clinical and non-clinical factors influencing postoperative health-related quality of life in patients with colorectal cancer. British Journal of Surgery, 95(11), 1408–1415. doi:10.​1002/​bjs.​6376.PubMedCrossRef
29.
Zurück zum Zitat Tsunoda, A., Nakao, K., Hiratsuka, K., Tsunoda, Y., & Kusano, M. (2007). Prospective analysis of quality of life in the first year after colorectal cancer surgery. Acta Oncologica (Stockholm, Sweden), 46(1), 77–82. doi:10.1080/02841860600847053.CrossRef Tsunoda, A., Nakao, K., Hiratsuka, K., Tsunoda, Y., & Kusano, M. (2007). Prospective analysis of quality of life in the first year after colorectal cancer surgery. Acta Oncologica (Stockholm, Sweden), 46(1), 77–82. doi:10.​1080/​0284186060084705​3.CrossRef
30.
Zurück zum Zitat Rapkin, B., & Schwartz, C. (2004). Toward a theoretical model of quality-of-life appraisal: Implications of findings from studies of response shift. Health and Quality of Life Outcomes, 2, 14. doi:10.1186/1477-7525-2-14.PubMedCrossRef Rapkin, B., & Schwartz, C. (2004). Toward a theoretical model of quality-of-life appraisal: Implications of findings from studies of response shift. Health and Quality of Life Outcomes, 2, 14. doi:10.​1186/​1477-7525-2-14.PubMedCrossRef
31.
Zurück zum Zitat Hjermstad, M. J., Fayers, P. M., Bjordal, K., & Kaasa, S. (1998). Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: The QLQ = C30 (+3). Journal of Clinical Oncology, 16(3), 1188–1196.PubMed Hjermstad, M. J., Fayers, P. M., Bjordal, K., & Kaasa, S. (1998). Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: The QLQ = C30 (+3). Journal of Clinical Oncology, 16(3), 1188–1196.PubMed
33.
Zurück zum Zitat Velikova, G., Wright, E. P., Smith, A. B., Cull, A., Gould, A., Forman, D., et al. (1999). Automated collection of quality-of-life data: A comparison of paper and computer touch-screen questionnaires. Journal of Clinical Oncology, 17(3), 998–1007.PubMed Velikova, G., Wright, E. P., Smith, A. B., Cull, A., Gould, A., Forman, D., et al. (1999). Automated collection of quality-of-life data: A comparison of paper and computer touch-screen questionnaires. Journal of Clinical Oncology, 17(3), 998–1007.PubMed
35.
36.
Zurück zum Zitat Pietrobon, R., Taylor, M., Guller, U., Higgins, L., Jacobs, D., & Carey, T. (2004). Predicting gender differences as latent variables: Summed scores, and individual item responses: A methods case study. Health and Quality of Life Outcomes, 2, 59. doi:10.1186/1477-7525-2-59.PubMedCrossRef Pietrobon, R., Taylor, M., Guller, U., Higgins, L., Jacobs, D., & Carey, T. (2004). Predicting gender differences as latent variables: Summed scores, and individual item responses: A methods case study. Health and Quality of Life Outcomes, 2, 59. doi:10.​1186/​1477-7525-2-59.PubMedCrossRef
Metadaten
Titel
Are gender-associated differences in quality of life in colorectal cancer patients disease-specific?
verfasst von
Johannes Giesinger
Georg Kemmler
Verena Mueller
August Zabernigg
Beate Mayrbaeurl
Josef Thaler
Dietmar Öfner
Christian Pegger
Gerhard Rumpold
Barbara Weber
Barbara Sperner-Unterweger
Bernhard Holzner
Publikationsdatum
01.06.2009
Verlag
Springer Netherlands
Erschienen in
Quality of Life Research / Ausgabe 5/2009
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-009-9468-0

Weitere Artikel der Ausgabe 5/2009

Quality of Life Research 5/2009 Zur Ausgabe